Skip to main content

Clinical Trial Results


Dr. James Januzzi and Dr. C. Michael Gibson Discuss: A Selective Aldose Reductase Inhibitor (at-001) For The Treatment Of Diabetic Cardiomyopathy: Primary Results Of The Phase 3 Randomized Controlled Arise-hf Study

Loader Loading…
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download [1.88 MB]

Disclosures: TBD